Maribavir Impurity 10
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

142356-40-9Maribavir Impurity 10

● In Stock

Catalogue No.:VE0028062
CAS No.:142356-40-9
Mol. Formula:C7H3BrCl2N2
Mol. Weight:265.92 g/mol

Additional information on CAS 142356-40-9

Parent drug

Maribavir

IUPAC Name

2-Bromo-5,6-dichloro-1H-benzo[d]imidazole

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

ClC1=C(Cl)C=C2C(NC(Br)=N2)=C1

InChI

InChI=1S/C7H3BrCl2N2/c8-7-11-5-1-3(9)4(10)2-6(5)12-7/h1-2H,(H,11,12)

Description

Maribavir Impurity 10 (CAS 142356-40-9) is a synthesis-related contaminant monitored for its effect on drug substance quality and stability. This impurity exhibits distinctive chromatographic retention and mass spectral fragments that facilitate detection by HPLC-PDA and LC-MS/MS. Formation pathways indicate susceptibility to hydrolytic and oxidative conditions during intermediate processing, making process parameter control and in-process sampling critical. Robust analytical methods, validated limits and forced-degradation studies are recommended to define acceptable levels and support regulatory filings. Characterizing its physicochemical properties enables targeted mitigation strategies in route optimization and ensures consistent impurity profiling for quality assurance.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url